Although cardiovascular disease remains the main cause of disability and premature death
worldwide, the past decade has seen a dramatic fall in the morbidity and mortality …

Therapy in cardiology has advanced enormously in recent years. This has resulted in the
organization of many meetings and the publication of numerous books dedicated to …

Drugs for the Heart summarizes the full breadth of cardiovascular pharmacology in a
compact, concise format. The book is organized by class of drug: P-blocking agents, nitrates …

Cardiovascular disease (CVD) is the leading health burden in the United States, contributing
significantly to morbidity and mortality. 1 Traditional CVD risk factors, including hypertension …

This selective review of a few of the advances made in recent years indicates that we are
entering a new era in cardiovascular pharmacology. Drugs with novel mechanisms of action …

Few areas of medical practice have developed more in the past 30 years than the drug
treatment of cardiovascular diseases. Indeed, in view of the steadily rising knowledge on …

The contemporary management of patients with ischemic heart disease demands a sound
understanding of the pathophysiologic precipitants of both angina pectoris and myocardial …

This year Cardiovascular Drugs and Therapy celebrates its 25th year of publication. In 1986
the journal, commonly known by its abbreviated title CDT, was founded by Henry Neufeld …